92 results
Page 3 of 5
8-K
EX-10.1
krzgh4gjuj
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
S-8
bnl 8ylfoek
6 Aug 20
Registration of securities for employees
4:07pm
S-8
EX-5.1
ap33xxgebb3asp
6 Aug 20
Registration of securities for employees
4:07pm
S-8
EX-99.2
7pkxc5x zcw5wej2e8ud
6 Aug 20
Registration of securities for employees
4:07pm
10-Q
EX-10.1
sgpo8qaj61ul08umulss
7 May 20
Quarterly report
4:03pm
10-Q
jc740t
7 May 20
Quarterly report
4:03pm
DEF 14A
xal 1m4wkth4
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
7ofe357l eujnql
14 Apr 20
Preliminary proxy
4:46pm
8-K
EX-10.2
lwhh06oe
20 Mar 20
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
4:11pm
8-K
EX-10.3
uzusmxefny3i6l
20 Mar 20
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
4:11pm
8-K
EX-10.1
rpc7p5t552
20 Mar 20
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
4:11pm
8-K
f1vg8x i7
20 Mar 20
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
4:11pm
8-K
EX-10.4
rgo vzzoxov0qm
20 Mar 20
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
4:11pm
POSASR
EX-1.2
bairbgbrf
28 Feb 20
Automatic shelf registration (post-effective amendment)
12:00am
POSASR
wcpqvgxzgqk
28 Feb 20
Automatic shelf registration (post-effective amendment)
12:00am
10-K
EX-10.13
h4semhatemei90nxvirw
27 Feb 20
Annual report
4:02pm